Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000320
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
1999-09-20
Brief Title:
Buprenorphine Formulation Comparison Sublingual Tablet vs Solution - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Buprenorphine Formulation Comparison Sublingual Tablet vs Solution
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare subject response to liquid vs tablet formulations to assess bioequivalency of liquid vs tablet to compare subject preference and to evaluate if dose response curve for tablet is equal to liquid form
Detailed Description:
1 Compare subjects response to liquid vs tablet formulation 2 Assess bioequivalency of liquid vs tablet 3Compare subject preference 4 Evaluate if dose response curve for tablet to liquid form
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-10068-1 | None | None | None |